Immunosuppressive therapy for aplastic anemia: a single-center experience from western India

Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine A (CsA) is the first-line therapy for acquired aplastic anemia (AA) in those not suitable for bone marrow transplant. Horse ATG (hATG) is preferred for this purpose, but its use is often impeded by shortages and costs...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sandip, Jain, Preetam, Shah, Kamlesh, Patel, Kinnari, Parikh, Sonia, Patel, Apurva, Panchal, Harsha, Anand, Asha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334724/
https://www.ncbi.nlm.nih.gov/pubmed/30173288
http://dx.doi.org/10.1007/s00277-018-3487-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334724/
https://www.ncbi.nlm.nih.gov/pubmed/30173288
http://dx.doi.org/10.1007/s00277-018-3487-2

Ejemplares similares